Exploratory Trial of Lurbinectedin and Radiotherapy in SCLC Progression
An exploratory trial is assessing the safety of combining lurbinectedin with radiotherapy in patients with SCLC showing single-lesion progression.
Therapeutic Area
Therapeutic area intelligence for SCLC with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No related entities indexed yet.
No catalysts indexed for this entity yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.